Published research context is included to summarize laboratory findings only and does not imply clinical use or therapeutic development
Ipamorelin: 100-300 mcg per injection CJC-1295 (no DAC / mod GRF 1-29): 100-300 mcg per injection Frequency: 1-3 injections daily, subcutaneous, ideally on an empty stomach or 90 minutes after the last meal and before sleep Cycle length: 12-24 weeks followed by a 4-to-8-week break to avoid GH receptor downregulation Injection site: Abdomen, approximately 1-2 inches from the navel, rotating sites each injection The pre-sleep injection is prioritized because it coincides with the largest endogenous GH pulse, which occurs roughly 60-90 minutes after sleep onset and is tied to slow-wave sleep [8]
Ipamorelin holds no Health Canada human or veterinary use authorization, so administering the peptide to a person or animal would step outside that designation
At Lone Star Center for Health and Wellness, our experienced and highly trained medical professionals ensure your IV therapy is delivered safely and comfortably in a relaxing environment
Conclusion The Sermorelin & Ipamorelin Blend represents a compelling conceptual framework within peptide research, uniting two mechanistically distinct signaling molecules under a shared regulatory objective
